Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study ; volume:147 ; number:1 ; day:30 ; month:12 ; year:2023 ; pages:1-12 ; date:6.2024
Acta neuropathologica ; 147, Heft 1 (30.12.2023), 1-12, 6.2024
- Creator
-
Montoliu-Gaya, Laia
Alosco, Michael L.
Yhang, Eukyung
Tripodis, Yorghos
Sconzo, Daniel
Ally, Madeline
Grötschel, Lana
Ashton, Nicholas J.
Lantero-Rodriguez, Juan
Sauer, Mathias
Gomes, Bárbara
Nilsson, Johanna
Brinkmalm, Gunnar
Sugarman, Michael A.
Aparicio, Hugo J.
Martin, Brett
Palmisano, Joseph N.
Steinberg, Eric G.
Simkin, Irene
Turk, Katherine W.
Budson, Andrew E.
Au, Rhoda
Farrer, Lindsay
Jun, Gyungah R.
Kowall, Neil W.
Stern, Robert A.
Goldstein, Lee E.
Qiu, Wei Qiao
Mez, Jesse
Huber, Bertrand Russell
Alvarez, Victor E.
McKee, Ann C.
Zetterberg, Henrik
Gobom, Johan
Stein, Thor D.
Blennow, Kaj
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-023-02660-3
- URN
-
urn:nbn:de:101:1-2024031312173147479680
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Montoliu-Gaya, Laia
- Alosco, Michael L.
- Yhang, Eukyung
- Tripodis, Yorghos
- Sconzo, Daniel
- Ally, Madeline
- Grötschel, Lana
- Ashton, Nicholas J.
- Lantero-Rodriguez, Juan
- Sauer, Mathias
- Gomes, Bárbara
- Nilsson, Johanna
- Brinkmalm, Gunnar
- Sugarman, Michael A.
- Aparicio, Hugo J.
- Martin, Brett
- Palmisano, Joseph N.
- Steinberg, Eric G.
- Simkin, Irene
- Turk, Katherine W.
- Budson, Andrew E.
- Au, Rhoda
- Farrer, Lindsay
- Jun, Gyungah R.
- Kowall, Neil W.
- Stern, Robert A.
- Goldstein, Lee E.
- Qiu, Wei Qiao
- Mez, Jesse
- Huber, Bertrand Russell
- Alvarez, Victor E.
- McKee, Ann C.
- Zetterberg, Henrik
- Gobom, Johan
- Stein, Thor D.
- Blennow, Kaj
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias